Stephen M Bloch
CIK 1400308 · last filed 2026-07-24
Stephen M Bloch is a corporate insider who has filed 80 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider sold $17.8M of LQDA on Jul 24, 2026. Across all open-market trades the lifetime net is −$307.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $49.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$49.22M
3
80
-$307.01M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LQDA | Director | 735,665 | $66.91 | $49.22M | -$118.66M | 19 | 2026-07-24 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 618,479 | $0.55 | $340.2K | $5.00M | 5 | 2016-02-04 |
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Director | 1,652,390 | $14.49 | $23.94M | -$193.34M | 50 | 2009-02-12 |
Recent Filings
80 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-24 | LQDA | Sell (S) | −200,000 | -$17.79M | EDGAR |
| 2026-07-22 | LQDA | Sell (S) | −78,596 | -$6.29M | EDGAR |
| 2026-07-08 | LQDA | Sell (S) | −75,000 | -$6.05M | EDGAR |
| 2026-07-06 | LQDA | Sell (S) | −25,000 | -$1.99M | EDGAR |
| 2026-06-24 | LQDA | Sell (S) | −100,000 | -$7.57M | EDGAR |
| 2026-06-18 | LQDA | Grant (A) | +5,882 | $0 | EDGAR |
| 2026-06-16 | LQDA | Sell (S) | −196,111 | -$14.01M | EDGAR |
| 2026-06-12 | LQDA | Sell (S) | −388,223 | -$26.63M | EDGAR |
| 2026-06-10 | LQDA | Sell (S) | −220,835 | -$14.27M | EDGAR |
| 2026-06-08 | LQDA | Sell (S) | −84,800 | -$5.51M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.